Skip to main content

Table 2 Characteristics of patients in the training set

From: Genomic transcriptional profiling identifies a candidate blood biomarker signature for the diagnosis of septicemic melioidosis

Sample ID Age (years) Sex Bacterial isolation Antibiotherapy before blood collection Underlying diseases Survival
Other sepsis (n = 13)       
   I001* 52 Male Streptococcus non-group A or B Ceftriaxone - Non-survivor
   I002†‡ 52 Female A. baumannii Ceftazidime, bactrim T2D, CRF, lung edema Survivor
   I004* 45 Male Salmonella serotype B Cloxacillin, ceftriaxone T2D, arthritis Survivor
   I006* § 37 Male C. albicans Ceftriaxone, sulperazone, bactrim HIV infection, tuberculosis Survivor
   I007* 73 Female Corynebacterium spp. - NSAID-induced GI bleeding Non-survivor
   I008†¶ 70 Female E. coli Bactrim, ceftazidime T2D Survivor
   I009* 52 Female S. aureus Ceftazidime, cloxacillin T2D, knee abscess Survivor
   I010†‡¥ 72 Female E. coli Ceftriaxone T2D, CRF Survivor
   I011* 38 Female E. coli - HCV infection Survivor
   I012* § 69 Female C. albicans Ceftazidime RF Survivor
   I013* 74 Female Corynebacterium spp. Ceftazidime, clarithromycin Chronic heart failure, COPD Survivor
   I014* 54 Female Salmonella spp. Ceftriaxone, ceftazidime, levofloxacin T2D, endometrial cancer, ITP Survivor
   I015* § 41 Male C. albicans Ceftazidime HIV infection Survivor
Septicemic melioidosis (n = 11)       
   M001* 68 Male B. pseudomallei Ceftazidime, bactrim Chronic heart failure, COPD Non-survivor
   M002* 43 Female B. pseudomallei Ceftriaxone, ceftazidime T2D Survivor
   M003* 55 Male B. pseudomallei Ceftazidime - Non-survivor
   M006* 46 Male B. pseudomallei Ceftriaxone T2D, chirrosis Non-survivor
   M007* 50 Male B. pseudomallei Ceftazidime, tazocin Lung cancer Survivor
   M008* 70 Female B. pseudomallei Ceftazidime, bactrim T2D Non-survivor
   M009* 48 Female B. pseudomallei Sulperazone T2D Survivor
   M010* 48 Male B. pseudomallei Ceftriaxone, ceftazidime, doxycycline T2D Survivor
   M012* 56 Male B. pseudomallei Sulperazone, bactrim, cetazidime T1D, ARF Survivor
   M014* 65 Female B. pseudomallei Cloxacilin, ceftazidime T2D, chirrosis Non-survivor
   M015* 41 Male B. pseudomallei Bactrim, ceftazidime - Survivor
  1. *Community-acquired septicemia; hospital-acquired septicemia;mechanical ventilation;§taken immunosuppressive;urinary catheterized drugs; ¥blood transfused. ARF, acute renal failure; COPD, chronic obstructive pulmonary disease; CRF, chronic renal failure; GI, gastrointestinal tract; NSAID, non-steroidal anti-inflammatory drug; RF, renal failure; T2D, type 2 diabetes; TP, idiopathic thrombocytopenic purpura.